Telehealth provider GobyMeds faces scrutiny over dose-based GLP-1 pricing
Consumer-facing review examines whether the GLP-1 seller increases monthly charges as patients titrate to higher doses.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 16 23:47 ETSource: PlexusDx
The wire
- 01A consumer review assesses whether GobyMeds raises GLP-1 prices as patient doses escalate.
- 02Dose-tiered pricing affects affordability for patients on long-term GLP-1 therapy.
- 03No independent verification of the provider's pricing structure is presented.
From the source
Read at news.google.comDoes GobyMeds Raise GLP-1 Prices When Your Dose Increases? — 2026